Page 4 of 8
Where was this study done?
Study sites were in 18 countries.
Number of patients who received at least one dose of the
study medicines
Argentina 76
Australia 14
Belgium 8
Canada 13
France 10
Germany 16
Italy 51
Mexico 43
Peru 22
Poland 9
Portugal 20
Romania 21
Russia 87
Spain 97
Switzerland 13
Taiwan 55
United Kingdom 28
United States 136
0 50 100 150
Number of patients
What were the main results of the study?
Study doctors collected blood samples and measured patientsâ€™ viral load on Day 1 and
during the study.
The main results of the study compared the percentage of patients with a viral load of
less than 50 c/mL at Week 48 in both the treatment groups. The study also compared
the percentage of patients with a viral load of less than 50 c/mL at Week 96 and
Week 144 in both the treatment groups.